Zobrazeno 1 - 10
of 64
pro vyhledávání: ''
Autor:
Douglas B. Johnson, Javid Moslehi, Joe-Elie Salem, Bénédicte Lebrun-Vignes, Eleonora De Martin, Aurore Vozy
Publikováno v:
European Journal of Cancer. 123:112-115
Autor:
Wade T. Iams, Brian I. Rini, Kathryn E. Beckermann, Matthew D Tucker, Douglas B. Johnson, Yu-Wei Chen
Publikováno v:
European Journal of Cancer
Autor:
Elisa Guerrero, Anne Bachelot, Bénédicte Lebrun-Vignes, Douglas B. Johnson, Javid Moslehi, Joe-Elie Salem
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2019, 113, pp.10-13. ⟨10.1016/j.ejca.2019.03.002⟩
European Journal of Cancer, Elsevier, 2019, 113, pp.10-13. ⟨10.1016/j.ejca.2019.03.002⟩
International audience
Autor:
Shinobu Noji, Reiko Muramatsu, Takashi Ohtsuka, Ikuo Kamiyama, Tetsuya Mitsudomi, Haruna Nagumo, Tomonori Yaguchi, Miyuki Saito, Yutaka Kawakami, Yuichiro Hayashi, Emi Takahata, Kaoru Kaseda, Masaki Shimoji, Chie Kudo-Saito, Nobuo Tsukamoto, Tomonari Kinoshita, Kenji Tomizawa, Hisao Asamura, Toshiharu Sakurai, Tomonobu Fujita
Publikováno v:
European Journal of Cancer. 86:15-27
We have previously demonstrated that the prognostic significance of tumour-infiltrating CD8+ T cells significantly differs according to histological type and patient smoking habits in non-small cell lung cancer (NSCLC). This work suggested that infil
Autor:
Christian U. Blank, Michele Maio, Michael A. Postow, Benjamin Weide, Phillip Wong, Dirk Schadendorf, Anna Maria Di Giacomo, Florian Heubach, Jianda Yuan, Paolo A. Ascierto, Amir Khammari, Marnix H Geukes Foppen, Brigitte Dréno, Graham Pawelec, Claus Garbe, Emanuela Romano, Domenico Mallardo, Bastian Schilling, Jedd D. Wolchok, Kilian Wistuba-Hamprecht, Alexander Martens
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2017, 73, pp.61-70. ⟨10.1016/j.ejca.2016.12.011⟩
European Journal of Cancer, Elsevier, 2017, 73, pp.61-70. 〈10.1016/j.ejca.2016.12.011〉
European Journal of Cancer, Elsevier, 2017, 73, pp.61-70. ⟨10.1016/j.ejca.2016.12.011⟩
European Journal of Cancer, 2017, 73, pp.61-70. ⟨10.1016/j.ejca.2016.12.011⟩
European Journal of Cancer, Elsevier, 2017, 73, pp.61-70. 〈10.1016/j.ejca.2016.12.011〉
European Journal of Cancer, Elsevier, 2017, 73, pp.61-70. ⟨10.1016/j.ejca.2016.12.011⟩
International audience; The role of the assessment of peripheral T-cell phenotypes in predicting overall survival (OS) after ipilimumab treatment is unclear. Here, we analysed mononuclear cells in the blood before and at different time points during
Autor:
Johanna P. van Geffen, Linda Sanders, Marijke J.E. Kuijpers, Maureen J.B. Aarts, Johan W. M. Heemskerk, Siamack Sabrkhany, Arjan W. Griffioen, Mirjam G.A. oude Egbrink, Sharo Pineda, Nadine J.A. Mattheij
Publikováno v:
Sabrkhany, S, Griffioen, A W, Pineda, S, Sanders, L, Mattheij, N, van Geffen, J P, Aarts, M J, Heemskerk, J W M, Egbrink, M G A O & Kuijpers, M J E 2016, ' Sunitinib uptake inhibits platelet function in cancer patients ', European Journal of Cancer, vol. 66, pp. 47-54 . https://doi.org/10.1016/j.ejca.2016.07.016
European Journal of Cancer, 66, 47-54. Pergamon
European Journal of Cancer, 66, 47-54. ELSEVIER SCI LTD
European Journal of Cancer, 66, 47-54. Pergamon
European Journal of Cancer, 66, 47-54. ELSEVIER SCI LTD
Background: Sunitinib is an oral tyrosine kinase inhibitor used for cancer treatment. Patients treated with sunitinib are at higher bleeding risk. As tyrosine kinases are essential for platelet signalling, the effects of sunitinib on platelet functio
Autor:
Ming-Ming Tsai, Chung-Ying Tsai, Chia-Siu Wang, Kwang-Huei Lin, Liang-Mou Kuo, Hsiang-Cheng Chi, Pei-Hsuan Lu, Kam-Fai Lee, Hsiang-Wei Huang, Yang-Hsiang Lin, Chung-Guei Huang
Publikováno v:
European Journal of Cancer. 64:137-148
miR-196a and/or miR-196b, involved in cancer initiation and progression, are frequently upregulated in tumour tissues. However, the clinical significance of these microRNAs in gastric cancer (GC) remains to be clarified. In the current study, we inve
Autor:
Julia K. Tietze, Ralf Gutzmer, Claus Garbe, Lucie Heinzerling, Jessica C. Hassel, Anja Gesierich, Andrea Forschner, Friedegund Meier, Michael C. Kirchberger, Lisa Zimmer, Carmen Loquai, Ursula Dietrich, Carsten Weishaupt, Reinhard Dummer, Ioannis Thomas, Renate Ursula Wahl, Simone M. Goldinger, Martin Leverkus, Dirk Schadendorf, Carola Berking, Jochen Utikal, Thomas Eigentler, Angela M. Krackhardt, Lars Hofmann, Daniela Göppner, Selma Ugurel, Gerold Schuler, Maria I. Schmidgen
Publikováno v:
European Journal of Cancer. 60:210-225
Anti-programmed cell death 1 (PD-1) antibodies represent an effective treatment option for metastatic melanoma and other cancer entities. They act via blockade of the PD-1 receptor, an inhibitor of the T-cell effector mechanisms that limit immune res
Publikováno v:
European Journal of Cancer
Aim of the study Melanoma subtypes have different aetiological characteristics. Child height is positively associated with adult melanoma; however, a clarification of associations with specific melanoma variants is necessary for an improved understan
Autor:
Duncan C. Gilbert, Ian N. Hampson, Charles Bailey, Andrew G Renehan, Lynne Hampson, Xiaotong He, Bipasha Chakrabarty, Anthony W. Oliver, Jeff Summers, Ivona Baricevic
Publikováno v:
European Journal of Cancer. 51:776-785
Characterisation of human papilloma virus (HPV) infection in anal squamous cell carcinoma (ASCC) may have dual importance: first, aetiological; second, prognostic, informing outcome after chemo-radiotherapy (CRT). We undertook HPV genotyping, and all